A perhaps unexpected role of norepinephrine in actions of MDMA

Clinical Pharmacology and Therapeutics

Volumn 90, Issue 2, 2011, Pages 215-216

  Newton, T F ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; NORADRENALIN; NORADRENALIN TRANSPORTER; REBOXETINE;

DRUG EFFECT; DRUG MECHANISM; HUMAN; NORADRENALIN UPTAKE; PRIORITY JOURNAL; REVIEW;

ADRENERGIC UPTAKE INHIBITORS; DRUG INTERACTIONS; HALLUCINOGENS; HUMANS; MORPHOLINES; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 79960601705     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2011.125     Document Type: Review

References (8)

1. Liechti, M.E., Baumann, C., Gamma, A. & Vollenweider, F.X. Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram. Neuropsychopharmacology 22, 513-521 (2000). (Pubitemid 30145619)
2. Liechti, M.E., Geyer, M.A., Hell, D. & Vollenweider, F.X. Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin. Neuropsychopharmacology 24, 240-252 (2001). (Pubitemid 32144810)
3. Liechti, M.E. & Vollenweider, F.X. The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ("Ecstasy") in healthy volunteers. J. Psychopharmacol. 14, 269-274 (2000).
4. Hysek, C.M. et al. The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans. Clin. Pharmacol. Ther. 90, 246-255 (2011).
5. Tainter, M.L. & Chang, D.K. The antagonism of the pressor action of tyramine by cocaine. J. Pharmacol. Exp. Ther. 30, 193-207 (1927).
6. Weinshenker, D. & Schroeder, J.P. There and back again: a tale of norepinephrine and drug addiction. Neuropsychopharmacology 32, 1433-1451 (2007). (Pubitemid 46920149)
7. Brown, Z.J., Tribe, E., D'Souza N.A. & Erb, S. Interaction between noradrenaline and corticotrophin-releasing factor in the reinstatement of cocaine seeking in the rat. Psychopharmacology (Berl) 203, 121-130 (2009).
8. Shaham, Y., Shalev, U., Lu, L., De Wit, H. & Stewart, J. The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl) 168, 3-20 (2003). (Pubitemid 36851158)